Evaluation of the Association Between DNA Methylation and Shortened Survival in Patients With Advanced Colorectal Cancer Treated With 5-FU/Oxaliplatin-Based Regimens in E3200.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Jun 2014

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Bevacizumab (Primary) ; Carboplatin; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin; Paclitaxel
Indications Colorectal cancer
Focus Therapeutic Use

09 May 2009 New source identified and integrated (ClinicalTrials.gov record NCT00897754).
28 Jan 2008 Broad-label approval was based on the results of this study and NO16966 [see 700003183].
26 Apr 2007 Status change

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com